網頁

星期三, 6月 29, 2016

Eurofins Lancaster Laboratoriesopens office in Cambridge, Mass.

Eurofins Lancaster Laboratories expands Northeast footprint; opens office in Cambridge, Mass.

CAMBRIDGE, Mass. Eurofins Lancaster Laboratories, a global leader in bio/pharmaceutical laboratory services, announced today the opening of itsNortheast office, located in the Cambridge Innovation Center (CIC) in Cambridge,Massachusetts.

“The strength of Massachusetts’ Life Sciences cluster continues to attract leaders in biopharmaceutical development,” said Governor Charlie Baker. “The talent and resources available here are unparalleled, and we are committed to supporting the success of companies like Eurofins Lancaster Laboratories.”

“As we forge strategic partnerships in supporting our clients’ scientific advancements and deliver innovative and timely solutions to the BioPharma industry, joining the Cambridge Innovation Center enhances our Northeast presence and officially places us at the hub of a prime biotech market,” said Timothy S. Oostdyk, Ph.D., Chairman, Eurofins Lancaster Laboratories; Group Sr. Vice President, Eurofins BioPharma Product Testing. “We are pleased to expand our sites into Massachusetts and serve as a valuable resource to our existing and future clients there, as well as make a positive impact on the Cambridge community.”

As a global leader in BioPharmaceutical product testing to the world’s largest pharmaceutical and biopharmaceutical companies, Eurofins Lancaster Laboratories brings the most comprehensive, compliant and collaborative laboratory testing services to the Northeast market. Backed by a 55-year successful track record, Eurofins Lancaster Laboratories offers a complete range of CMC Testing Services to support virtual and large bio/pharmaceutical companies and CMOs worldwide, including testing of all starting materials, process intermediates, bulk drug, finished product, and final packaging components through its broad technical expertise in Biochemistry, Molecular & Cell Biology, Virology, Chemistry and Microbiology.

“We are excited to welcome Eurofins Lancaster Laboratories to the Massachusetts Life Sciences ecosystem,” said Travis McCready President & CEO of the Massachusetts Life Sciences Center. “They are joining a strong and growing cluster of contract laboratory service providers in Massachusetts, including other global leaders in this sector that are playing a central role in the development of new treatments, therapies and cures for patients.  We look forward to being good partners with Eurofins as they put down roots and grow in the Commonwealth.”

“MassBio is thrilled to welcome Eurofins Lancaster Laboratories to the Massachusetts life sciences supercluster,” said Robert K. Coughlin, President & CEO of MassBio. “We know that Eurofins will bring value and benefit as they connect with new partners in our robust biopharma community, which increasingly relies on the important work of contract service providers.”